Last reviewed · How we verify

NCT05880225

Reciprocal Imitation Training and Musical Rhythm Sensitivity in Autistic Toddlers

Recruiting now NA Last updated 25 April 2025
What this trial tests

NA trial testing Reciprocal Imitation Training in Autism in 40 participants. Currently enrolling.

Timeline
3 July 2023
Primary endpoint
30 April 2026
30 April 2026

Quick facts

Lead sponsorVanderbilt University Medical Center
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date3 July 2023
Primary completion30 April 2026
Estimated completion30 April 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Vanderbilt University Medical Center

Who can join

Adults 18 Months to 36 Months, any sex, with Autism or Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary goal of this study is to examine rhythm sensitivity as a predictor of response to naturalistic developmental behavioral intervention (NDBIs) in autistic toddlers. Toddlers receive either Reciprocal Imitation Training (RIT), an evidence-based NDBI that supports children's imitation and social communication skills, or a music-enhanced version of RIT. Throughout their participation in the intervention, toddlers will complete study procedures of viewing naturalistic videos of infant-directed singing and other social scenes while eye gaze data is collected.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Reciprocal Imitation Training

Trials testing the same drug.

Other recruiting trials for Autism

Currently open trials in the same condition.

Other Vanderbilt University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05880225.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing